Sign in

Vilija Vėlyvytė

@vvelyvyte.bsky.social
182 followers 62 following 12 posts

Academic @ King’s College London | award-winning author | EU and public law | fmr. British Academy Postdoctoral Fellow @ Oxford Law & Emile Noël Fellow @ NYU Law | DPhil Law, MPhil Law, MJur @ Oxford, Weidenfeld scholar

PostsRepliesMedia
Reposted by Vilija Vėlyvytė
UK in a Changing Europe @ukandeu.bsky.social · 02/09/2026
"Brexit also exposed the UK to a form of pressure that EU membership had shielded it from." 💊 @vvelyvyte.bsky.social reflects on the UK-US medicines deal and argues the terms are a hidden cost of Brexit 🔗 ukandeu.ac.uk/the-uk-us-me...
ukandeu.ac.uk
The UK-US medicines deal and the hidden costs of Brexit - UK in a changing Europe
Vilija Vėlyvytė argues that the UK-US medicines deal which will see the NHS pay more for new medicines is an unexpected cost of Brexit.
097
Vilija Vėlyvytė @vvelyvyte.bsky.social · 28/08/2026
An opinion piece by me for Comment Central: commentcentral.co.uk/the-uk-us-me... Having shrunk the scale of the market and opportunity the UK can offer the pharmaceutical industry, Brexit has weakened the UK’s bargaining power and, with it, its ability to resist US tariff pressure.
commentcentral.co.uk
The UK-US Medicines Deal is a Hidden Cost of Brexit
The government recently published the terms of the UK–US medicines deal agreed late last year. This deal should be understood as one of Brexit’s hidden costs...
000
Vilija Vėlyvytė @vvelyvyte.bsky.social · 22/08/2026
Everything you need to know about what has happened to UK law and policy since Brexit. Fresh off the press!
001
Vilija Vėlyvytė @vvelyvyte.bsky.social · 19/08/2026
In my new blog post for @ukandeu.bsky.social, I argue that the UK–US medicines deal, which will see the NHS pay more for new medicines, is one of Brexit’s hidden costs. Brexit has weakened the UK’s bargaining power and, with it, its ability to resist US tariff pressure.
002
Vilija Vėlyvytė @vvelyvyte.bsky.social · 10/03/2026
The UK government's rhetoric portrays international recruitment into the NHS as an uncomfortable necessity – tolerated to plug current gaps, but politically undesirable and expected to recede as domestic capacity builds. I argue this approach needs to change.
001
Vilija Vėlyvytė @vvelyvyte.bsky.social · 05/03/2026
Steve Weatherill and I consider the "fate" of mutual recognition as an organising principle of EU internal market law and explore its evolving relationship with legislative harmonisation. E.L. Rev. 2026, 51(1), 84-103, access via Westlaw UK.
011
Vilija Vėlyvytė @vvelyvyte.bsky.social · 01/08/2025
Today, I officially start as Lecturer in EU Law at King’s College London. I’m thrilled to be joining a leading law school with a deep and long-standing tradition in EU law research and teaching. This is also a major personal milestone following three career breaks (and three beautiful babies).
110
Vilija Vėlyvytė @vvelyvyte.bsky.social · 15/05/2025
Just wrapped up Day 3 of the workshop for our forthcoming volume The UK Regulatory Framework Post-Brexit: ‘Law Unbound’ (OUP 2026). Huge thanks to our 33 (!!!) fantastic contributors and to my exceptional co-editor, Paul Craig. Watch this space!
110
Vilija Vėlyvytė @vvelyvyte.bsky.social · 15/12/2024
I had the pleasure to review an incredibly interesting and highly valuable book: Not What The Bus Promised by @tamarahervey.bsky.social, @ivankaantova.bsky.social, Mark Flear, and Matthew Wood. I strongly recommend it to anyone who’s interested in all things Brexit and health governance.
061